Volume 14 - Issue 6 - June 2017

Craig Walker, MD
Clinical Editor
Interventional Cardiologist 
Founder, President, and Medical Director
Cardiovascular Institute of the South
Clinical Professor of Medicine 
Tulane University School of Medicine
Louisiana State University School of Medicine

Dr. Walker discusses this month’s article by Gupta, et al. and comments on the potential merit of a gel foam technique for treating patients with dangerous bleeds secondary to invasive procedures. | Read More

Craig Walker, MD
Clinical Editor
Vascular Disease Management

Dr. Craig Walker, Clinical Editor, welcomes three new Section Editors to the VDM team: Dr. Richard Kovach, section editor on Carotid Disease; Dr. Pradeep Nair, clinical section editor on New Technologies; and Dr. Amjad AlMahameed, section editor on… | Read More

Paramjit Chopra, MD2;  Zsuzsanna Igyarto, PhD1;  Brad J. Martinsen, PhD1

Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States. | Read More

Krishna Kumar Bhaskarapillai, DNB (Pediatrics), DNB (Cardiology)1;  Praveen Velappan, MD, DM (Cardiology)2;  Prabha Nini Gupta, MD, DM (Cardiology)2;  Ashish Singal, MD2;  Vijayalekshmi Ambika, MD2

We describe here an endovascular approach to a perforation in the right femoral artery that was emergently closed with gel foam. | Read More

Akhilesh K. Sista, MD

This article covers pulmonary embolism (PE) stratification, pathophysiology, and endovascular therapy for massive and submassive PE. | Read More

Jovan N. Markovic, MD and Cynthia K. Shortell, MD, FACS

Because the management of congenital arteriovenous malformation (CVM) falls within the purview of many medical specialties, it is critical to establish a multidisciplinary approach. This article offers tips for the diagnosis and treatment of CVMs. | Read More

Michael D. Dake, MD

The Gore Thoracic Branch Endoprothesis is a novel, single-branch stent-graft designed and initially studied for the treatment of thoracic aortic aneurysms in zone 2. We discuss the expansion of this device for use in zones 0 and 1. | Read More